IL2 and neuroblastoma: These data support the conclusion that neuroblastoma tumors are rich in cytokines that are potentially immunosuppressive (IL-6, IL-10, and TGFβ1) but not in cytokines that support NK cell proliferation, differentiation, and activation (IL-2, IL-15, IL-12).